The QualityStocks Daily Wednesday, October 2nd, 2019

Today's Top 3 Investment Newsletters

QualityStocks (OWCP) +50.53%

CannabisNewsWire (HTC.V) +35.09%

MarketClub Analysis (TSG) +30.05%

The QualityStocks Daily Stock List

Alkane Resources Limited (ANLKY)

InvestorIntel, StreetWise Reports, Penny Stock Hub, Connecting Investor, OTC Markets, Wallmine, Wallet Investor, and InvestorsHub reported earlier on Alkane Resources Limited (ANLKY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alkane Resources Limited is a gold production company with a multi-commodity exploration and development portfolio. It is currently focused on gold exploration, production, as well as investment. Alkane has projects and operations located in the Central West of New South Wales, eastern Australia. In addition, the Company is a gold producer via its wholly-owned subsidiary, Tomingley Gold Operations (TGO). Alkane Resources has its head office in Burswood, Australia. The Company’s shares trade on the OTC Markets’ OTCQX.

Alkane Resources also maintains offices and operations in eastern Australia. This includes Narromine Shire – home of its producing gold mine, Tomingley Gold Operations and its highly prospective tenement package. Furthermore, Alkane has an office in Parkes Shire – home of its Peak Hill Gold Mine and further exploration tenements. Additionally, the Company has an office in Dubbo Regional Council LGA – home of its world-class, construction-ready, multi-commodity Dubbo Project.

Alkane Resources’ most significant project is the Dubbo Project, owned by Alkane subsidiary, Australian Strategic Materials (ASM), which stands to become a strategic and significant international producer of zirconium, certain rare earths, hafnium and niobium. The Dubbo Project has a potential mine life of 70-plus years. It is the most advanced project of its kind outside China.

The gold operations at Tomingley are approximately 50 kilometers south-west of Dubbo in Central West NSW. Operated by Tomingley Gold Operations (TGO), the wholly-owned subsidiary of Alkane Resources, the gold processing plant was commissioned on time and on budget in January of 2014. It has been operating at the design capacity of 1Mtpa from early 2014.

Mining at Tomingley is based on four gold deposits (Wyoming One, Wyoming Three, Caloma and Caloma Two.) Open cut mining occurred on the deposits until early in 2019 producing 60,000 to 80,000 ounces of gold per year. Underground mining began in early 2019 from the bottom of the Wyoming One pit.

Alkane Resources has made a discovery of significant porphyry gold-copper mineralization at its Boda prospect, within the Northern Molong Porphyry Project (NMPP) in central west NSW. The NMPP incorporates three exploration licences, encompassing an area of 110 km2 of the northern Molong Volcanic Belt. The area is considered highly prospective for large porphyry gold-copper mineralization, as demonstrated by the world class Cadia Valley porphyry district, situated to the south of the volcanic belt.

In September, Alkane Resources reported drill results from its Tomingley Gold Project in central west NSW, showing further significant gold intercepts within the “Tomingley Gold Corridor”. Drilling is taking place to seek to define an initial inferred resource at the San Antonio and Roswell prospects with a nominal 40 meter by 40 meter drill hole spacing to a 200 meter vertical depth. Assay results have now been received for the next 5,000 meters of drilling, with intercepts ranging between 2.33 g/t and 26.1 g/t.

The resource definition drilling is part of a wide-ranging regional exploration program centered on the immediate mine area to the south of Tomingley with the goal of providing additional ore feed, either at surface or underground, in the future to Tomingley Gold Operations (TGO).

Alkane Resources Limited (ANLKY), closed Wednesday's trading session at $4.54, off by 6.3918%, on 1,000 volume with 2 trades. The average volume for the last 3 months is 1,323 and the stock's 52-week low/high is $1.29999995/$5.32200002.

chart

Birchcliff Energy Ltd. (BIREF)

OilandGas360, Top Stocks News, Canadian Insider, Energy Now, Market Screener, Simply Wall St, GlobeNewswire, Stockhouse, TradingView, MarketBeat, Stockwatch, and Business Insider reported earlier on Birchcliff Energy Ltd. (BIREF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Birchcliff Energy Ltd. explores for, develops, and produces natural gas, crude oil, and natural gas liquids in Western Canada. An intermediate oil and natural gas company, it has operations concentrated within its one core area, The Peace River Arch Of Alberta. Birchcliff has substantial in-house technical expertise and experience on the Peace River Arch. Established in 2004, Birchcliff Energy is headquartered in Calgary, Alberta. The Company lists on the OTC Markets.

Birchcliff has focused assets in the Peace River Arch Area of Alberta on the Montney/Doig Resource Play. It essentially has a 100 percent working interest (WI); 99 percent of production is operated. The Company has a large, contiguous undeveloped land base with an average 89 percent WI.

Birchcliff Energy has significant control of infrastructure. This includes the 100 percent owned and operated 340 MMcf/d Pouce Coupe Gas Plant (PC Gas Plant). Additionally, it has a low decline production base (estimated 20 percent in 2019), and a top tier cost structure driving peer leading profitability.

Birchcliff also has a 2P reserve life index (RLI) of about 35.6 years as at December 31, 2018. It had 385 (380.6 net) Montney/Doig horizontal wells drilled as at December 31, 2018. Furthermore, the Company had 6,365.8 net future potential Montney/Doig horizontal drilling locations as at December 31, 2018.

Birchcliff Energy’s key strategic attributes include 18 gross (15.1 net) Montney sections contiguous to existing BIR infrastructure. There is the potential for 4 Montney intervals (Montney D1, D2, C, Basal Doig/Upper Montney).

In Q1 2019, the Company drilled a 6 well pad. It was be completed and brought on production in Q3 2019. The strategic land acquisition provides additional liquids rich drilling inventory to fill the Pouce Coupe Gas Plant. This acquisition included approximately 700 boe/d of legacy production. The acquisition was evaluated primarily on land acquisition metrics and future drilling opportunities. The construction of the 340 MMcf/d PC Gas Plant is in six separate phases.

This past August, Birchcliff Energy announced its financial and operational results for the three and six months ended June 30, 2019 and an expanded 2019 capital program. Selected Q2 2019 highlights include Production averaging 78,453 boe/d (6% light oil, 7% condensate, 9% NGLs and 78% natural gas). This represents a 3% increase from Q2 2018. Liquids production weighting grew by 3% from Q1 2019 and by 8% from Q2 2018.

The Company had Adjusted Funds Flow of $74.0 million, or $0.28 per basic common share. This represents a 2% increase and a 4% increase, respectively, from Q2 2018. Birchcliff produced $6.0 million of free funds flow in Q2 2019. Birchcliff’s Net Loss to Common Shareholders was $9.5 million, or $0.04 per basic common share versus the Net Income to Common Shareholders of $6.4 million and $0.02 per basic common share in Q2 2018. The Company had record low operating expense of $3.17/boe. This represents a 6% decrease from Q2 2018.

Birchcliff Energy expanded its 2019 capital program (the 2019 Capital Program) to include the drilling and bringing on production of an additional 7 (7.0 net) HZ wells in 2019. The expectation is that F&D capital expenditures will now be $242 million.

Birchcliff Energy Ltd. (BIREF), closed Wednesday's trading session at $1.5256, off by 2.828%, on 54,280 volume with 53 trades. The average volume for the last 3 months is 185,078 and the stock's 52-week low/high is $1.28900003/$3.98000001.

chart

CCUR Holdings, Inc. (CCUR)

Pitch Book, Zacks, Stock Twits, Vintage Value Investing, Simply Wall St, Market Screener, Stocksholm, Seeking Alpha, Insider Tracking, 4-Traders, YCharts, Stockhouse, Value Walk, TipRanks, MarketWatch, The Street, Stockwatch, Last10k, and InvestorsHub reported beforehand on CCUR Holdings, Inc. (CCUR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CCUR Holdings, Inc operates MCA and real estate business segments by way of its subsidiaries Recur Holdings LLC and LM Capital Solutions, LLC. In addition, the Company actively pursues other business opportunities to maximize the value of its assets via evaluation of additional operating businesses or assets for acquisition. CCUR Holdings has its corporate headquarters in Duluth, Georgia. The Company lists on the OTC Markets Group’s OTCQB.

CCUR’s assets include its real estate operations operated through subsidiary Recur Holdings. CCUR Holdings operates by way of its subsidiary LM Capital Solutions, LLC that identifies and places capital with originators of merchant cash advance (MCA) financings with established track records of MCA underwriting and servicing excellence, and via its subsidiary Recur Holdings, LLC, which conducts, holds and manages real estate operations.

CCUR Holdings announced in February of this year that through its newly created subsidiary, LM Capital Solutions, LLC (LMCS), it closed on a Purchase Agreement to acquire the operating assets of LuxeMark Capital, LLC. LuxeMark operates via its syndication network to facilitate merchant cash advance (MCA) funding through connecting a network of MCA originators with syndicate participants who provide those originators with more capital by purchasing participation interests in funded MCAs. Also, LuxeMark uses its expertise in the MCA industry to provide servicing and other administrative services to its syndicate network.

For Q4 of Fiscal 2019, CCUR Holdings reported Net Income attributable to its stockholders of $803,000, or $0.09 per share. During the prior year period, CCUR reported a Net Loss of $1,700,000, or ($0.18) per share.

Revenue for the quarter increased to $1,846,000 versus $54,000 during the prior year period and $1,074,000 in Q3 of Fiscal 2019. Merchant Cash Advance (MCA) Revenue rose to $1,435,000 and Revenue From Interest On Loans increased to $411,000. Other Interest, Dividend And Investment Income for the period totaled $1,770,000.

CCUR Holdings, Inc. (CCUR), closed Wednesday's trading session at $3.49, off by 1.4124%, on 7,375 volume with 4 trades. The average volume for the last 3 months is 3,296 and the stock's 52-week low/high is $3.00/$4.8499999.

chart

Edgewater Wireless Systems, Inc. (KPIFF)

Market Screener, StockPulse, TalkMarkets, Morningstar, Dividend Investor, Wallet Investor, Stockhouse, Stockwatch, OTC Markets, Frontier Small Caps, Insider Tracking, Trading View, MarketWatch, and GuruFocus reported beforehand on Edgewater Wireless Systems, Inc. (KPIFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Edgewater Wireless Systems, Inc. concentrates on Wi-Fi infrastructure with its patented WiFi3™ technology and Next Generation Access Points. The Company commercializes inventive wireless technologies for the service provider market. Edgewater Wireless is developing considerably improved Wi-Fi network performance across an variety of industries and challenging environments with first-rate performance, high flexibility, and consummate security. The Company is the industry leader in Wi-Fi Spectrum Slicing technology for residential and commercial markets. Edgewater Wireless Systems is based in Ottawa, Ontario and the Company lists on the OTCQB.

Established in 1988 by Edgewater Computer Systems, Edgewater Wireless Systems has an international distribution network. The Company has invested more than $50 Million in the development of Edgewater Wireless Products. It has sales partners in the UK, Brazil, Peru, Asia and the U.S.

Edgewater is backed by more than 24 patents. The Company has entered into discussions with a number of prospective strategic partners in pursuing licensing opportunities for its patented Wi-Fi Spectrum Slicing solutions. This is complementing its silicon work.

Edgewater Wireless is patented, standards-compliant Wi-Fi delivering many concurrent channels of transmit and receive on a single radio in 2.4GHz & 5GHz – called Wi-Fi Spectrum Slicing. MCSR powers its products. Edgewater Wireless WiFi3™ powered access point products enable innovative service providers to plan, build, and deploy reliable, high-capacity services (such as VoWiFI) for high-density & data demand in any environment.

Edgewater delivers the highest channel density available on the contemporary market. The Company uses Edgewater Wireless patented technology, which enables numerous channels on a single chip. As a result, aggregate output on a single WiFi3™ powered AP will outperform traditional, single channel APs.

This week, Edgewater Wireless Systems announced financial and operating results for its quarter ended July 31, 2019. Regarding Q1 2020 highlights, the Company stated that Q1 was a challenging quarter as it faced significant silicon manufacturing issues. Strategically, Edgewater attained a vital milestone in producing its next generation of MCSR™ silicon solutions. The Company anticipates moving to tape-out cost-optimized silicon later in 2019.

Mr. Andrew Skafel, President and Chief Executive Officer of Edgewater Wireless Systems, said, “While revenues for the quarter were disappointing, our team has made significant strides in creating a scalable platform for our next generation of silicon production. The emerging Dual Channel Wi-Fi™ standard is opening up licensing opportunities to the Company, which a year ago, were not visible.”

Edgewater Wireless Systems, Inc. (KPIFF), closed Wednesday's trading session at $0.0694, off by 10.2199%, on 2,000 volume with 2 trades. The average volume for the last 3 months is 38,590 and the stock's 52-week low/high is $0.050999999/$0.119999997.

chart

Emerald Health Therapeutics, Inc. (EMHTF)

Investing Haven, Midas Letter, Technical420, New Cannabis Ventures, Stockwatch, Daily Marijuana Observer, NIC Investors, Proactive Investors, Trading View, Micro Cap Daily, Small Cap Power, Stock of the Week, Green Leaf Pot Stocks, Pot Stock News, Micro Small Cap, Wallet Investor, GuruFocus, Insider Financial, and Stockhouse reported earlier on Emerald Health Therapeutics, Inc. (EMHTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. The Company is a Health Canada Licensed Producer (LP) of medical cannabis with decades of experience in pharmaceutical innovation. Emerald is leveraging industry-leading life sciences, cannabis and greenhouse growing expertise to achieve highly competitive low cost, value-added cannabis products. Emerald Therapeutics is based in Victoria, British Columbia and the Company’s shares trade on the OTC Markets Group’s OTCQX.

Emerald Therapeutics is part of the Emerald Health group. The Emerald Health group is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits through interacting with the human body’s endocannabinoid system. Emerald Health Therapeutics’ focus is on enhancing health via cannabis science. It produces and sells dried cannabis and cannabis oil for medical and recreational purposes.

Emerald is a vertically integrated, seed-to-sale enterprise. The Company has combined core competencies from decades of experience in pharmaceutical innovation with large-scale agriculture expertise centered on developing value-added cannabis-based products with potential wellness and medical benefits.

Emerald entered into a strategic alliance with Factors R&D Technology, Inc., a division of Factors Group of Nutritional Companies, Inc., Canada’s largest nutritional supplement marketer and manufacturer. This exclusive arrangement provides access to an industrial-scale production facility, capable of processing up to 1M kg of biomass annually and softgel production capacity of up to 600M capsules annually.

Emerald Health Therapeutics has secured cannabis supply agreements with the Provinces of British Columbia, Alberta, Saskatchewan, Ontario, Québec, Newfoundland and Labrador, and the Yukon Territory. It is advancing prospective supply agreements with all remaining provinces and territories to develop a major presence in the recreational market.

Emerald purchased 500 acres of harvested hemp chaff in 2018 and up to 1,000 acres in 2019 to 2022 from Emerald Health Hemp, Inc. CBD (cannabidiol) extract from hemp biomass will be used in the Company’s medical and adult-use products.

Emerald’s 50 percent-owned Pure Sunfarms joint venture (JV) in British Columbia is licensed to cultivate in 1.03 million square feet of the first of its two 1.1 million square foot greenhouses. The capacity of each greenhouse is estimated to exceed 75,000 kg of cannabis annually. Emerald also has its Verdélite operation in Québec that is completing the build out of its 88,000 square foot indoor cultivation facility and scaling up production.

Last month, Emerald Health Therapeutics and HelloMD, a top online cannabis healthcare company, announced a partnership to further streamline and enhance Emerald’s patient onboarding experience. As part of the new partnership, Emerald has integrated HelloMD's industry-leading turnkey virtual services and patient onboarding solutions into its program for medical cannabis patients. Patients are offered 7 days-a-week access to independent, practitioner-led advice concerning medical cannabis. Interested patients connect securely online with a licensed practitioner. The process is free of charge for patients who use the online service through Emerald’s website.

In addition, in September, Emerald Health Therapeutics announced that its 50 percent-owned JV for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms (PSF), formally launched its Pure Sunfarms branded products and introduced eight strains of dried cannabis flower for the Canadian recreational marketplace. Moreover, it has started shipping branded dried cannabis products to the Ontario Cannabis Store (OCS) for retail sale in the Province of Ontario.

Emerald Health Therapeutics, Inc. (EMHTF), closed Wednesday's trading session at $0.9504, up 2.7237%, on 359,250 volume with 541 trades. The average volume for the last 3 months is 245,546 and the stock's 52-week low/high is $0.809069991/$4.05999994.

chart

Lixte Biotechnology Holdings, Inc. (LIXT)

OTC Markets, Research and Markets, Emerging Growth, Simply Wall St, Last10k, Small Cap Network, Market Screener, InvestorsHub, Stockopedia, Dividend Investor, Wallet Investor, Street Insider, PR Newswire, 4-Traders, GuruFocus, MarketBeat, Stockhouse, and Morningstar reported previously on Lixte Biotechnology Holdings, Inc. (LIXT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. Its product pipeline is primarily centered on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or X-ray and immune checkpoint blockers. A clinical-stage pharmaceutical enterprise, Lixte Biotechnology Holdings has its head office in East Setauket, New York. The Company’s shares trade on the OTCQB.

Lixte Biotechnology has identified molecular signaling pathways altered in disease states. It has also designed compounds that can safely target them in animal models. The Company’s present drug portfolio includes inhibitors of serine/threonine protein phosphatases critical to cell division and DNA damage repair and inhibitors of protein deacetylases, which regulate pathways of gene expression and protein degradation.

The phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general and radiation therapy. This makes them potentially useful for the treatment of numerous cancers in combination with existing standard chemotherapy regimens and with the developing targeted cytotoxic therapies of personalized cancer medicine.

Furthermore, in a pre-clinical study done with scientists under collaborative research and development agreements at the National Institutes of Health, Lixte Biotechnology’s lead compound, LB-100, enhanced the antitumor activity of a major immune checkpoint inhibitor. Therefore, this raises the possibility that in addition to improving the efficacy of standard cytotoxic anti-cancer drugs, Lixte’s phosphatase inhibitors may potentiate immunotherapy regimens (Ho 2017).

This past July, Lixte Biotechnology announced that the first patient was enrolled in its Phase 1b/2 study of the safety and therapeutic benefit of the Company’s lead clinical compound, LB-100, in patients with low and intermediate-1 risk myelodysplastic syndrome (MDS) who have failed or are intolerant of standard treatment (NCT03886662).

Dr. John S. Kovach, Founder and Chief Executive Officer of Lixte Biotechnology, said “Because there are no standard treatments for patients with refractory MDS, from a statistical standpoint as few as 7 objective responses among the first 47 patients would be considered encouraging and justify proceeding to a Phase 3 trial. Of course, we hope that in the current trial LB-100 will be associated with even higher rates of objective benefit to these patients allowing us to move to Phase 3 before reaching 47 entries.”

Lixte Biotechnology has signed a clinical trial agreement with the Spanish Sarcoma Group (Grupo Español de Investigación en Sarcomas, GEIS) to support a Phase 1b/randomized Phase 2 study of doxorubicin, the international standard for initial treatment of advanced soft tissue sarcomas (ASTS), in comparison to doxorubicin plus LB-100.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Wednesday's trading session at $1.35, even for the day. The average volume for the last 3 months is 1,656 and the stock's 52-week low/high is $0.600000023/$1.45000004.

chart

Simlatus Corporation (SIML)

Zacks, Stock Scores, Market Wire News, Simply Wall St, Stockaholics, Financial Insiders, Stockwatch, Emerging Growth, Stock Target Advisor, Financial Buzz, Investing.com, Wallet Investor, MarketBeat, and Real Investment Advice reported beforehand on Simlatus Corporation (SIML), and we also report on the Company, here at the QualityStocks Daily Newsletter.

A holding company, Simlatus Corporation centers on opportunities in the cannabis space. It owns and operates a number of subsidiaries with manifold revenue streams in the CBD (cannabidiol) industry. Proscere Bioscience is the Company’s division focused on the CBD industry. Simlatus has its corporate office in Grass Valley, California. The Company’s shares trade on the OTC Markets.

Simlatus’ diversity includes other subsidiaries, such as Satel Group. Satel is a premier high-rise DirecTV provider for the financial, commercial and residential metropolitan San Francisco Bay area. Additionally, the Company’s subsidiaries include Simlatus, a manufacturer of audio/video products, which currently sells to DirecTV, CBS, Fox News and Warner Bros.

Simlatus manufactures and markets commercial High-Definition (HD) and Analog audio/video systems for the global broadcast studio industry. It continues to lead the commercial industry with high-end equipment. The Company’s “SyncPal™ and Simlatus-IBS™ are for revolutionizing studio management and audio/video control using smartphones or smart glasses.

Pertaining to the Digital Media and Augmented/Virtual Reality device industry, Simlatus’ SocialCast AR and Augmented/Virtual Reality Content Server products will allow the Company to expand into high-growth digital television and over-the-top (OTT) markets. It is developing technologies in Virtual Reality, Augmented Reality, Audio/Video Codecs, Audio Content Recognition, as well as OTT API Integration.

Regarding CBD, Simlatus announced in September negotiations with a major pharmaceutical company in Europe concerning a potential $200M initial order. Simlatus initially discussed its Hybrid Cold/Water – Alcohol based CBD Extraction system in Europe in December 2018 with a major pharmaceutical company. Moreover, Proscere Bioscience is positioning itself to supply the pharmaceutical industry with CBD extraction systems to produce pharmaceutical-grade THC (tetrahydrocannabinol) and CBD as a replacement for opiate based Schedule-II prescription drugs.

Furthermore, Simlatus announced recently that between March and August of 2019 it has prepaid 5 notes for a total principal, interest and penalties of more than $2M. Pursuant to the 8K filing of September 16, 2019, Simlatus is finalizing the delivery of 14 CBD Extraction Systems in value of $24M. More negotiations are taking place with different groups for additional systems.

Simlatus Corporation (SIML), closed Wednesday's trading session at $0.0015, off by 11.7647%, on 31,933,358 volume with 120 trades. The average volume for the last 3 months is 21,016,515 and the stock's 52-week low/high is $0.0003/$0.165000006.

chart

Natural Health Farm Holdings, Inc. (NHEL)

Stockopedia, Stockhouse, Market Exclusive, Capital Cube, 4-Traders, Street Insider, Morningstar, Simply Wall St, InvestorsHub, OTC Markets, GuruFocus, MarketWatch, Last10k, and Barchart reported earlier on Natural Health Farm Holdings, Inc. (NHEL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natural Health Farm Holdings, Inc. is a biotechnology company working to establish a complete healthcare one-stop shop based on natural or naturopathic products. Since November of 2017, the Company has developed and started to commercialize the web-based Naturopathic Learning Management System to enable consumers and distributors to be educated on health-related aspects of various diseases and nutritional consulting services. Natural Health Farm Holdings is headquartered in Las Vegas, Nevada. The Company lists on the OTCQB.

Natural Health Farm provides online nutritional consultation services. It does so through offering a web-based naturopathic learning management system. This system educates their customers on general wellbeing. The Company’s principal activities are in retailing nutritional supplements, organic foods and health-care related products.

Via its subsidiary, NHF International Limited, Natural Health Farm specializes in biotechnology research & development, and a retail business. It has a chain of numerous retail & franchise outlets throughout Malaysia and other nations. These include Singapore, Brunei, Philippines, China, Hong Kong and the United States.

Natural Health Farm Holdings announced this past January that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Tech R&D Sdn Bhd, a BioNexus accredited research and development company in Malaysia. With the agreement, Natural Health Farm shall acquire 100 percent of Natural Tech R&D’s outstanding shares for USD 1 Million.

Natural Health Farm Holdings also announced in January that it executed a term sheet to acquire all of the issued and outstanding shares of Excel Herbal Industries Sdn Bhd. Excel Herbal is a nutraceutical biotechnology manufacturing, organic food and health supplements business in Malaysia.

Recently, Natural Health Farm Holdings announced that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Health Naturopathic Academy Sdn Bhd (NHNA), a Malaysian healthcare education provider. Natural Health Naturopathic Academy offers courses on health, nutrition, dietetic and Chinese & natural medicine, which are accredited by over 30 countries.

Natural Health Farm Holdings also recently announced that it executed a term sheet to acquire a majority equity interest in Biodelta (Pty) Ltd. Biodelta is a contract developer and manufacturer of nutraceutical products in South Africa. Furthermore, this month, the Company announced that it executed an agreement to acquire all the issued and outstanding shares of Natural Health Farm, Inc. (NHF). NHF is a distributor of naturopathic and nutraceutical products in North Carolina and throughout the East Coast of the United States.

Natural Health Farm Holdings, Inc. (NHEL), closed Wednesday's trading session at $0.001, up 400.00%, on 5,000 volume with 1 trade. The stock's 52-week low/high is $0.071999996/$6.00.

chart

Empire Diversified Energy, Inc. (MPIR)

PennyStockHub, Equity Net, Otc Dynamics, Hot Penny Stocks, MarketWatch, Penny Stock Tweets, Dividend Investor, Biz Journals, OTC Markets, InvestorsHub, Morningstar, Investing, Stockhouse, Stockopedia, YCharts, and Investors Hangout reported beforehand on Empire Diversified Energy, Inc. (MPIR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Empire Diversified Energy, Inc.’s primary goal is to serve the challenges of the energy Industry with inventive solutions mainly related to the safe removal and disposal of Coal Combustion Residue (CCR), typically referred to as coal ash, from the nation’s utilities storage ponds. Fundamentally, the Company’s mission is to help clean up the existing environment and develop clean fuel sources in the future. Empire specializes in Diversified Green Energy projects. It is a full-service business. OTCQB-listed, Empire Diversified Energy is based in Fort Lauderdale, Florida.

The Company is currently initiating coal-reduction strategies involving increased use of sustainable biomass. Furthermore, Empire’s longer-term plans will be to diversify into zero-emission fuel science and the broad use of economically-viable hydro-electric, solar, and wind technologies. Empire provides strategic consulting and unique environmental solutions to address industry issues including the CCR remediation and renewable energy alternatives. The Company has identified a niche market opportunity in the fly ash remediation sector.

Empire plans to acquire certain assets. These include, but are not limited to, logistical equipment, coal mines, landfills, solar equipment, and biomass inventories. This is because it is working to implement a vertical integration strategy. It is now developing a hybrid alternative fuel pellet (HAFP). The intention of HAFP is to permit utilities and other enterprises that now burn solid and gaseous fuel sources to transition from these traditional sources to HAFP’s. Empire is also developing its own proprietary binding agent. This binding agent will allow HAFP’s to be used across a broader array of platforms.

Recently, Empire Diversified Energy announced that it received the first tranche of investment funds from a private equity group. The funds were used to pay off existing debt related to the Dickerson site in Cadiz, Ohio and to expand operations at the site. This funding retired the remaining debt on the site, which was acquired with the purchase of 100 percent of the membership rights of DTE Dickerson LLC. A Michigan LLC in April of 2017. This financing also provides much needed working capital to expand the reclamation project.

Empire Diversified Energy, Inc. (MPIR), closed Wednesday's trading session at $0.50, up 25.00%, on 150 volume with 2 trades. The average volume for the last 3 months is 403 and the stock's 52-week low/high is $0.239899992/$2.00.

chart

OWC Pharmaceutical Research Corp. (OWCP)

Tip Ranks, InvestorsHub, MarketWatch, PR Newswire, Insider Financial, The Street, Stock Invest, OTC Markets, Promotion Stock Secrets, Street Register, The Profit Buzz, CFN Media Group, Seeking Alpha, Stockhouse, Morningstar, and Cannabis Financial Network News reported previously on OWC Pharmaceutical Research Corp. (OWCP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OWC Pharmaceutical Research Corp. engages in the research and development (R&D) of cannabis-based medical products. The Company provides medical products for the treatment of different medical conditions and/or diseases. These include multiple myeloma, psoriasis, PTSD, migraines, and delivery systems. OTCQB-listed, OWC Pharmaceutical Research is headquartered in Petach Tikva, Israel. One World Cannabis Ltd. is a wholly-owned subsidiary of OWC Pharmaceutical Research.

OWC has entered into research and collaboration agreements with three of the leading research institutions in Israel. These include Sheba Academic Medical Center, one of the top academic hospitals in the Middle East. These agreements serve as the basis for the Company’s clinical trials. They ensure that all of its studies have been, and will continue to be, founded on established research protocols of the U.S. Food and Drug Administration (FDA), Institutional Review Boards, and Independent Ethical Committees. 

OWC has completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. The technology behind the tablet is protected. It provides for the ingestion of almost any dosage of medical cannabis with a sublingual delivery mechanism, where the compounds are absorbed directly into the patient's blood by way of oral epithelial tissue.

Subsidiary One World Cannabis’ Research Division centers on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of diverse medical conditions. Its Consulting Division’s dedication is to helping governments and companies navigate complex international cannabis regulatory frameworks.

OWC has received the first ever Institutional Review Board (IRB) approval to conduct a safety study for a cannabis-based topical cream with more than 3 percent THC. The Company is conducting a safety study (FDA Phase 1 equivalent) in one of the largest academic hospitals in Israel.

Going forward, OWC Pharmaceutical Research’s comparative safety and efficacy trial for its tablet will be initiated in Q2 of 2019. The expectation is that the duration of this trial will be four months. Additionally, the efficacy trial for the Company’s cannabis cream will be initiated in Q3 of 2019. The duration of this trial is expected to be about 24 months.

Regarding its Multiple Myeloma (cancer therapy) program, OWC successfully completed a dosing study for its proprietary, systemic emulsion delivery system in rats. The Company’s pre-clinical results indicated strong potential of its cannabis-based formulations to kill cancer cell lines and tumors in mice. OWC stated that this important milestone was fundamental to enable the translation of these pre-clinical results into a potential therapy.

OWC Pharmaceutical Research Corp. (OWCP), closed Wednesday's trading session at $0.0143, up 50.5263%, on 9,445,007 volume with 225 trades. The average volume for the last 3 months is 1,119,202 and the stock's 52-week low/high is $0.006599999/$0.214499995.

chart

Medibio Limited (MDBIF)

Awesome Penny Stocks, Wallet Investor, The Street, TradingView, Morningstar, Penny Stock Hub, Stockwatch, OTC Markets, Investing Online, Otc.Watch, Investors Hangout, Stockhouse, 4-Traders, and Global Banking and Finance reported earlier on Medibio Limited (MDBIF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Medibio Limited is a digital health company with offices in Melbourne (Vic), and Minneapolis, Minnesota. It has developed an objective testing system to assist in the screening, diagnosis, and treatment effectiveness of depression, chronic stress, and other mental health disorders. The test uses patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms to deliver a quantifiable measure to assist in clinical diagnosis. Medibio lists on the OTC Markets’ OTCQB.

Medibio is on course to commercialize its platform technology called the Digital Mental Health Platform. The basis of this is on patented biomarkers from the autonomic nervous system. The Company’s technology will provide a Diagnosis Aid to help General Practioners (GPs) and mental health clinicians. Medibio’s technology provides the first objective measure of stress. It provides a series of user and corporate dashboards for assessment and wellness partner interventions.

Regarding biomarker based objective diagnosis, a panel of circadian, sleep, and automatic system biomarkers enables automated, repeatable, and objective characterization of the impact of mental illness on the physiologic state. Medibio’s Digital Mental Health Platform is a device agnostic platform. It can ingest data from many devices. It is highly scalable, low cost, as well as easy to integrate.

Medibio announced in October 2018 the release of ilumen™. This is its product and platform for corporate customers. ilumen™ is a corporate wellness product providing employers the ability to offer biometric analysis and objective, data-driven feedback along with a mental wellness assessment to their employees.

Recently, Medibio announced that it signed an exclusive agreement with AIAA to undertake a pilot program for the latest release of its corporate health program, ilumen™. AIAA is one of Australia’s leading life insurers. AIAA is part of the AIA Group, which is the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets around the Asia-Pacific region. AIAA will have access to ilumen™ over a six-month period for its Australia and New Zealand employees.

Medibio Limited (MDBIF), closed Wednesday's trading session at $0.009, up 28.5714%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 85,337 and the stock's 52-week low/high is $0.0013/$0.045000001.

chart

First Foods Group, Inc. (FIFG)

Stockwolf, Stockwatch, Wall-St, OTC Markets, Real Investment Advice, Investors Hangout, The Street, Market Screener, TradingView, Stockhouse, Penny Stock Hub, Euro Investor, YCharts, and MarketWatch reported on First Foods Group, Inc. (FIFG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

First Foods Group, Inc. has growing interests in the food and food service industry. The Company provides management services and financing options for new foodservice brands and menu concepts. Moreover, it is growing its new concepts through proprietary development and through mergers, acquisitions, and licensing arrangements. The Company formerly went by the name Litera Group, Inc. It changed its name to First Foods Group, Inc. in February 2017. First Foods Group has its head office in Las Vegas, Nevada.

First Foods Funding invests in short-term merchant cash advances that have been producing immediate high rates of return on capital. This Division continues to realize fast growth through the reinvestment of its profits while attracting substantial new funds from outside investors.

First Foods earlier signed cannabis business expert Mr. Robert Hunt, Esq. to identify opportunities in the legal cannabis industry where the Company’s management, expertise, and relationships could have considerable effect. Mr. Hunt is one of the distinguished consultants in the legalized marijuana industry. He has been instrumental in many of the best known and most successful cannabis businesses in operation today.

First Foods Group entered into a binding term sheet in April 2017 with globally renowned chocolatier and entrepreneur Mr. Oded Brenner. This is to fully develop Mr. Brenner’s new chocolate-based retail concept. The venture is jointly owned by First Foods Group and Mr. Brenner. Initial plans are to launch two flagship stores in New York, New York, and to immediately take advantage of numerous multi-unit global franchising opportunities. 

Holy Cacao is marketing premium chocolate products created and packaged by Holy Cacao consultant, Mr. Oded Brenner, founder of "Max Brenner, Chocolate by the Bald Man," for the legal cannabis sector. Mr. Brenner has incorporated an exotic mix of champagnes, sherries, and select cannabis strains into his chocolate formulas.

First Foods Group registered its Holy Cacao® subsidiary with the State of Nevada on August 31, 2017. The Company stated that Holy Cacao will soon be licensed as a THC product in the legal marijuana states.

First Foods Group recently reported GAAP Revenue of $85,510 for the second fiscal quarter of 2018. This represents an increase of 42 percent over the GAAP Revenue of $60,295 reported for the first fiscal quarter of 2018. The Company’s financial results are supporting the expansion of its Holy Cacao subsidiary. This subsidiary is finalizing negotiations to produce high-end chocolate, which will be sold and distributed to the edibles market using First Foods’ trademarked brand and packaging.

First Foods Group, Inc. (FIFG), closed Wednesday's trading session at $0.26, up 23.8095%, on 18,690 volume with 11 trades. The average volume for the last 3 months is 5,585 and the stock's 52-week low/high is $0.050999999/$0.600000023.

chart

Contact Gold Corp. (CGOL)

4-Traders, Stockhouse, 24hgold, and OTC Markets reported on Contact Gold Corp. (CGOL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A gold exploration company, Contact Gold Corp. concentrates on leveraging its properties, people, technology and capital to produce district scale gold discoveries in the State of Nevada. The Company's land position consists of 275 km2 of target rich mineral tenure hosting many known gold occurrences, ranging from early- to advanced-exploration and resource definition stage. Contact Gold has its corporate office in Vancouver, British Columbia.

The Company’s team is led by geologists, mining executives, finance and investment banking professionals. This team has considerable experience from Discovery to Mine Building. Contact Gold’s shareholders include Waterton Global Resource Management, Goldcorp, and a number of foremost mining focused institutional investors.

Contact Gold's wide-ranging land holdings are on the prolific Carlin, Independence and Northern Nevada Rift gold trends that host many gold deposits and mines. South Carlin Projects (135 km2) include Pony Creek, Dixie Flats and North Star; immediately southeast and northeast of Gold Standard Ventures.

In Q1 2018, Contact Gold started a 16,000-meter exploration drill program at the Pony Creek gold project. In addition, it further expanded the Pony Creek property with the acquisition of the 7.8 km2 East Bailey property. Pony Creek's North Zone now measures more than 1,000 meters in strike length and 300 meters wide. Most of the drill intercepts are oxidized or partially oxidized.

In Q1 2018, the Company also reported final 2017 drill results from Pony Creek's "Bowl Zone" and the "North Zone" target. This includes 2.12 g/t Au over 22.86 meters from 64.01 to 86.87 meters in drill hole PCC17-040 OXIDE, including 4.53 g/t Au over 9.14 meters from 65.53 to 74.67 meters OXIDE.

Drill results also include 0.59 g/t Au over 32.00 meters from 25.91 to 57.91 meters in drill hole PC17-41 OXIDE; and 3.95 g/t Au over 6.10 meters from 160.02 to 166.12 meters in drill hole PC17-19.

Pony Creek’s Bowl Zone is host to an historical mineral resource estimate. It features a substantial drilled footprint (1200 meters x 400 meters). There is room to expand in manifold directions, especially to the north towards the North Zone and to the northwest towards a number of planned 2018 drill targets.

Recently, Contact Gold announced drill results from the first five holes, totaling 983 meters, from its 2018 drill program at the Pony Creek Gold Property positioned on the Carlin Trend in Elko County, Nevada.

Mr. Matt Lennox-King, Contact Gold’s President & Chief Executive Officer, said, "We are very pleased with these initial results, particularly the intersection of the best high-grade oxide gold zone in a step out hole so far from the western edge of the Bowl Zone at Pony Creek. These results confirm our oxide targeting model and further demonstrate the excellent potential of our flagship project. The 99% gold recovery by cyanide assays in hole PC18-03 compared to the fire assays is extremely encouraging as we continue our focus on drilling higher-grade, oxidized gold mineralization."

Contact Gold Corp. (CGOL), closed Wednesday's trading session at $0.14, up 28.5583%, on 19,000 volume with 3 trades. The stock's 52-week low/high is $0.108900003/$0.384600013.

chart

Spindle, Inc. (SPDL)

TopPennyStockMovers and SmallCapVoice reported previously on Spindle, Inc. (SPDL), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Spindle, Inc. (dba CATALYST Commerce Solutions) is an emerging provider of integrated marketing and commerce solutions focused on the Small and Medium-sized Business (SMB) market. The Company is an innovator of merchant and consumer-facing commerce solutions. It is concentrating on pioneering new ways for businesses to quickly integrate mission critical business services, payment acceptance, and mobile marketing services. This is while empowering location-based merchant discovery, fulfillment, and frictionless consumer engagement. OTCQB-listed, Spindle is headquartered in Mesa, Arizona. 

The CATALYST Marketing System components and CATALYST IP were included in the asset acquisition from Catalyst Business Development, Inc. that Spindle completed in 2015. Catalyst Business Development is a Scottsdale, Arizona-based provider of payment gateway services, sales, and software solutions. 

Spindle’s commitment is to provide innovative solutions that surpass traditional boundaries, and allow clients, partners, merchants, and consumers to take full advantage of the fast-developing mobile economy. Spindle is focusing on payment processing services and integrating value-added capabilities that enhance merchant revenue and increase consumer loyalty, experience, and retention. 

The Company integrates acceptance channels. Spindle is also pushing the boundaries through adding big data collection, analytics, marketing, loyalty and points programs and integration with other domains (including security systems and business automation products). Regarding Point-Of-Sale (POS) & MPOS, Spindle has a POS solution built around the power of the cloud. This is for restaurants and retail to mobile vendors and event organizers. 

Spindle acquired Yowza!! - a provider of mobile couponing technology. This technology is integrated with Spindle's platform. Spindle signed distribution agreements with a broad array of channel partners. Via these relationships, it can provide wide-ranging mobile commerce services through many channels. These channels include wireless providers, vending services operators, and technology solutions providers. 

Spindle has finalized an agreement to acquire specific digital marketing software assets from CoverCake, Inc., specifically CoverCake's intelligent algorithms for data mining and consumer engagement. CoverCake's software is envisioned to enhance the sophistication and proprietary strengths of Spindle's CATALYST Platform. CoverCake's software capabilities include intelligent content aggregation; data mining on different social media data feed platforms, and a strong Content Management System (CMS) backend. 

Spindle has executed two strategic agreements with Concourse Team Express. With this strategic relationship, Team Express will use the CATALYST Team Sports Platform to offer teams the ability to manage their rosters, collect fees, integrate social media, team scheduling, statistics, location directions, and more. CATALYST Team Sports will be adding the Team Express custom teamwear and team store solutions to the platform. Team Express is a top multi-channel internet retailer.

Recently, Spindle announced the launch of the CATALYST Marketing System. The platform has been further enhanced through integrating the Company's customized CATALYST software with solution providers, the CATALYST Gateway, and its recently acquired software from CoverCake. The CATALYST Marketing System (CMS) enables SMBs the ability to manage their business from one central hub. 

Spindle, Inc. (SPDL), closed Wednesday's trading session at $0.0001, even for the day, on 52,500 volume with 2 trades. The average volume for the last 3 months is 480,627 and the stock's 52-week low/high is $0.000099999/$0.033199999.

chart

The QualityStocks Company Corner

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)

The QualityStocks Daily Newsletter would like to spotlight IONIC Brands Corp. (OTC: IONKF).

On September 18, 2019, IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) announced that it has secured eligibility from the Depository Trust Company (DTC) for its shares on the U.S. OTC Markets (http://cnw.fm/Hc2HJ). Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Montefiore Medical Center in New York is conducting a clinical trial which will examine the effects of cannabidivarin (CBDV) on the level of irritation and repetitive behaviors in autistic children. Cannabidivarin is a compound of marijuana that is nonpsychoactive and does not induce highness upon consumption.

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

  • IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
  • WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
  • ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
  • Vuber Technologies hardware produces the best vaporization experience on the market.
  • Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
  • Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.

IONIC Brands Corp. (OTC: IONKF), closed Wednesday's trading session at $0.034655, up 15.5167%, on 422,079 volume with 47 trades. The average volume for the last 3 months is 273,073 and the stock's 52-week low/high is $0.024399999/$0.634559988.

Recent News

chart

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted in a publication from HempWireNews, examining how, globally, industrial hemp is used in more than 250,000 products, and interest in this versatile plant doesn’t seem to have peaked just yet. For the first time, the World Ag Expo is going to feature a hemp pavilion where there will be space for exhibitors and a stage for seminars during the expo due to take place in February 2020.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Wednesday's trading session at $3.58, up 1.1299%, on 1,506,587 volume with 4,765 trades. The average volume for the last 3 months is 1,124,045 and the stock's 52-week low/high is $2.97000002/$8.43999958.

Recent News

chart

GP Solutions (OTC: GWPD)

The QualityStocks Daily Newsletter would like to spotlight GP Solutions (GWPD).

GP Solutions Inc. (OTC: GWPD), a leading developer of highly innovative, automated micro-farms under the trade name “GrowPods,” today announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW").

GP Solutions (OTC: GWPD) is developing scalable farming systems for soil-less indoor organic farming. The company’s GrowPods are automated micro-farms that use hydroponic technology and unique soil systems to cultivate the highest-quality specialty leaf crops. The system is designed and engineered for ease of use, allowing users to farm year-round in any location of the world, supporting the company’s mission to provide customers with the ability to cultivate their own organic “superfoods.”

GrowPod Design & Function

GrowPod is a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. GrowPods are available as a vertical pod, stacker pod or custom-built pod.

The Stacker Pod is a certified organic soil system that offers growers multiple levels of planting in order to maximize space and produce options with different fruits and vegetables. The Vertical Pod utilizes a vertical hydroponic system. It is affordable, scalable, efficient, automated and sustainable. The output provides customers with fresh and clean produce year-round in any climate. The Custom Pod is built to suit the farmer’s specific crop and grow goals.

Each 320-square-foot GrowPod container will have an annual production capability of up to four times that of outdoor growing methods, dramatically increasing profitability to the grower. The controlled environment of the GrowPod ensures efficient power and water usage in growing a wide range of horticultural and agricultural products in all environments and climates.

Thanks to a combination of hydroponic and certified organic soil systems, crop yields are higher, faster, and more consistent that conventional means. Customers can enjoy an average of eight higher yield crop cycles anywhere in the world.

GrowPod Features:

  • Modular, stackable and mobile
  • Fully insulated, food-grade shipping container
  • Engineered for automation
  • Efficient LED lighting
  • Hydroponic or soil-based platforms
  • Proprietary air and water filtration
  • Climate-controlled
  • Remote monitoring

GP Solutions also offers many services to its customers, including:

  • Shipment and installation service of its shipping container farms
  • On-site training
  • Provision of custom planting and harvesting schedule
  • Provision of growing supplies, seeds, nutrients, packaging, branding and repair materials
  • On-site visits, on-call and scheduled maintenance, and re-supply
  • Remote monitoring and automated control of environmental nutrients, environmental growth factors (PH, temperature, light) and circulation
  • Technical assistance
  • Consulting and custom facility systems design

Competitive Advantage

GrowPods allow cultivation to take place year-round, which maximizes ROI. The systems are sealed from outside pathogens, contaminants, pesticides, and the result is clean and robust crop production.

GP Solutions also has a line of remarkable new proprietary soil mixtures and nutrient lines which contain no animal products. These products are vital, as many other soils and additives can contain harmful pathogens and contaminants that can cause crops to become tainted or fail rigorous testing.

Global Solution

GP Solutions has partnered with the world’s leading food nonprofit companies, including Feeding America, Seeds of Hope, Habitat for Humanity, Meals on Wheels America, L.A. Kitchen, and Farm Bread, to help insecure communities take control of their own food dependence using container farms.

GP Solutions (GWPD), closed Wednesday's trading session at $2.15, up 3.1175%, on 29,113 volume with 61 trades. The average volume for the last 3 months is 4,885 and the stock's 52-week low/high is $1.03999996/$21.00.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, has completed a US $10 million investment (the "Investment") in TerrAscend Canada Inc. ("TerrAscend Canada"), a subsidiary of its portfolio company TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The investment includes the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of CA $1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrants of TerrAscend exercisable until October 2, 2024 (the "Warrants").

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Wednesday's trading session at $1.5295, off by 0.681818%, on 170,497 volume with 558 trades. The average volume for the last 3 months is 114,934 and the stock's 52-week low/high is $1.44807004/$5.40999984.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC).

HTC Extraction Systems (TSX.V: HTC), a gas, liquids and biomass extractor and refiner, recently reported financial results for the second quarter and six-month period ending June 30, 2019 (http://cnw.fm/t2btS). To view the full article, visit http://cnw.fm/8kJWk.

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (TSX.V: HTC), closed Wednesday's trading session at $0.385, up 35.0877%, on 161,300 volume with 26 trades. The average volume for the last 3 months is 200,115 and the stock's 52-week low/high is $0.079999998/$1.24.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) highlighted today in a publication from CBDWire, examining how, according to an analysis performed by Tastewise, an artificial intelligence (AI)-powered food trend analysis company, people are searching for functional benefits in what they eat and drink, and that is why cannabidiol (CBD) has picked traction so quickly among consumers.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Wednesday's trading session at $0.9732, up 4.4206%, on 392,025 volume with 376 trades. The average volume for the last 3 months is 392,802 and the stock's 52-week low/high is $0.843599975/$5.20499992.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. Montefiore Medical Center in New York is conducting a clinical trial which will examine the effects of cannabidivarin (CBDV) on the level of irritation and repetitive behaviors in autistic children. Cannabidivarin is a compound of marijuana that is nonpsychoactive and does not induce highness upon consumption.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Wednesday's trading session at $2.90, up 8.1081%, on 75,409 volume with 123 trades. The average volume for the last 3 months is 36,376 and the stock's 52-week low/high is $2.51999998/$6.00810003.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Consumer wellness brand cultivator Geyser Brands Inc. (TSX.V: GYSR) is rapidly building its revenue-generating operation thanks to the September completion of acquisition plans for hemp oil product manufacturer Solace Management, a company whose portfolio includes 57 SKUs of consumer wellness goods and pet care products (http://cnw.fm/f9IK2).

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed Wednesday's trading session at $0.49, even for the day, on 220 volume. The average volume for the last 3 months is 1,412 and the stock's 52-week low/high is $0.409999996/$0.850000023.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), through its proprietary BIGtoken platform, has developed a consumer-managed data marketplace where consumers can own their own data and earn rewards for the release of that data. To view the full article, visit http://nnw.fm/Ta18y.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday's trading session at $2.16, off by 2.7027%, on 76,693 volume with 288 trades. The average volume for the last 3 months is 74,371 and the stock's 52-week low/high is $1.54999995/$5.8499999.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology Inc. (NASDAQ: POAI) today announced that its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY® System for automated, direct-to-drain medical fluid disposal, has completed the sale of ten systems to the foremost teaching and research hospital in upstate New York.  According to U.S. News and World Report, the 800+ bed hospital has among the best clinical programs in the country.  The sale surpasses the company’s largest single hospital sale to date and is expected to generate 6000 procedures annually. Also today, the company was highlighted in a publication from Financialnewsmedia.com covering POAI’s announcement of the pricing of its previously announced public offering of its common stock, with anticipated gross proceeds of up to $3,167,768.50, before deducting placement agent fees and expenses and offering expenses payable by the Company.

Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Predictive Oncology (POAI), closed Wednesday's trading session at $0.50, off by 9.9099%, on 167,264 volume with 303 trades. The average volume for the last 3 months is 55,740 and the stock's 52-week low/high is $0.419999986/$0.850000023.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), a fully integrated, surface oil sands clean recovery mining oil company with proprietary technology, recently secured additional funding and made considerable headway toward its Asphalt Ridge heavy-oil extraction facility expansion plans. To view the full article, visit http://nnw.fm/GzwD7.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Wednesday's trading session at $0.1747, off by 12.65%, on 410,017 volume with 88 trades. The average volume for the last 3 months is 235,796 and the stock's 52-week low/high is $0.112099997/$1.00.

Recent News

chart

B2Digital Inc. (OTC: BTDG)

The QualityStocks Daily Newsletter would like to spotlight B2Digital Inc. (BTDG).

Florida-based B2Digital Inc. (OTC: BTDG) is building a launching pad for mixed martial arts (MMA) champions to enter the big leagues. The platform – B2 Fighting Series (B2FS) – is meant to be the Premier Development League for the mixed martial arts (MMA) marketplace, offering the best minor league fighters an arena to showcase their pluck and prowess to fans, as well as scouts from the big leagues. The development league got going on September 14, 2019, with the 12-fight Colosseum Combat 50 in Kokomo, Indiana, the first of 10 such events planned for the inaugural B2FS Fall Season.

B2Digital Inc. (OTC: BTDG) is applying its extensive background in entertainment, television, video and technology to become a full-service live event sports company. Capitalizing on its strong management team, industry relationship, and hands-on experience in the industry, B2Digital is developing and acquiring Mixed Martial Arts (MMA) and sports-related companies to build an integrated premier development league initially for the billion-dollar MMA marketplace.

B2Digital’s management team boasts over 30 years of combined global experience developing more than 20 companies within the sports, television, entertainment, digital distribution and banking transaction industries.

Since its restructuring in 2017, the company is now forging ahead with company chairman and CEO Greg P. Bell at the helm. His expertise, relationships and experience bring a background of more than 40,000 successful live events throughout his career. Under his guidance, B2Digital will create and develop the “Development League” champions that will move on to the MMA major leagues from within the B2 Fighting Series.

In preparation, B2Digital has produced and applied the systems and technologies required to support and maintain infrastructural operations of the company, including: social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems. The company has also launched its B2 Social Media Network as the digital distribution system for the B2 Fighting Series.

As part of its growth strategy, B2Digital intends to continue to develop and acquire assets that meet its business model with the goal of becoming a premier vertically integrated live event sports company. In 2017, B2Digital started operating B2 Fighting Series, live MMA events; each year, the top fighters are invited to the live annual B2 Fighting Series National Championship.

Assets

B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks and branding for the B2Digital companies. The company has deployed its B2 Social Media Network digital distribution network for the B2 Fighting Series and has developed and deployed the systems and technologies for the operation of social media marketing, event engagement, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems.

Fight Groups (holdings)

  • HRMMA
  • Colosseum Combat
  • United Combat League
  • Pinnacle Combat
  • Bluegrass MMA

B2 Social Media Network (B2SN)

The B2 Social Media Network (B2SN) provides the connection between the B2Digital live events and the consumer audience by:

  • Providing social interaction between consumers regarding B2Digital Properties and current relevant topics to the live events audience
  • Offering “FTV” free-to-view live and on-demand TV style broadcasts globally of B2 Digital live events
  • Promoting upcoming live events
  • Selling tickets to B2 live events electronically
  • Promoting the fighters, athletes and participants in the B2Digital live events

Download Report

Leadership

Chairman and CEO Greg P. Bell
Greg P. Bell is one of the early pioneers and entrepreneurs in entertainment and digital media and has been working in the field for over 30 years. He was involved in the early creation of the technologies and algorithms that allowed analog media to be transformed into digital bits and compressed data streams and created specific business enterprises that capitalized on the creation of digital transmissions at Scientific Atlanta, Compressions Labs, VCON International and Qwest. Bell was one of the initial vice presidents of business development at Qwest Communications where he developed Qwest’s digital media company, Slingshot Networks. He then ran all operations of Slingshot, reporting to the board of directors, which managed and operated three full time studios including the creation of the broadcast studio in Staples Center, TV and news productions, live events at the Staples Center, distribution of a national television show distributed by Warner Brothers TV Distribution, online television productions and web distribution for the NFL, AFL, NBA, NHL, Boxing, Democratic Convention and live music events.

Upon leaving Slingshot in 2000, Bell founded B3 Development Group, a firm specializing in developing emerging market entertainment and media companies. Bell’s B3 Development Group founded B2 Networks in 2001 which quickly became the defacto standard for watching live PPV sporting events online. B2’s proprietary online system broadcasts live professional and collegiate sporting events online to a global audience, broadcasting over 1,000 live games per month. Bell developed and implemented a merger with B2 Networks and the America ONE Television Network where he became CEO of the combined companies. Under Bell’s direction the company, now called ONE Media Corp., launched the new ONE World Sports TV Network in North America on cable and satellite, with a pure digital end-to-end distribution system, along with continuing the company’s growth in the online distribution of sports and entertainment.

After leaving as CEO of ONE Media Corp., he currently sits as chairman of B3 Development Group, which specializes in developing and fast-tracking emerging entertainment, transaction technology and media distribution companies. Bell continues to expand his holdings and currently has business holdings in ONE Media Corp; B3 Development Gaming Group which under contract with Caymanas Park Race Track, owned by the country of Jamaica, developed Jamaica’s first all-digital state of the art pari-mutuel live sports gaming system for mobile devices and currently is operating under the brand CaymanasToGO for the Caribbean Consumers and is licensed for deployment in the USA to USA-based consumers. The B3 Gaming Group mobile device wagering system and technology allows consumers globally to watch and wager on live horse races and sporting events being held in the UK, USA, Canada and the Caribbean; B3 Gaming Services Group, a premier transaction and customer service group that offers management services to the Gaming industry in the Caribbean, B3 Networks, a premier state of the art digital broadcasting company that developed the B3 television satellite replacement technology which allows TV networks to broadcast globally on the public internet instead of satellites in broadcast quality HD & SD television. B3 Networks has deployed, and services, the B3 technology to broadcast high definition TV signals globally to cable head ends, smart phones and internet connected devices for the Jamaica Education Television Network, the Caymanas Race Track and other mobile applications globally.

Bell has worked at the top technology development companies that developed the digital technologies, which are in use today at Scientific Atlanta, Compression Labs, VCON and Qwest. He also has managed and been directly involved with over 55,000 live events in his 30-year career. He has worked with a diverse group of clients in the entertainment, sports and technology communities including the NFL, NBA, NHL, AHL, NLL, ECHL, IFL, USHL, SPHL, NCAA, NAIA, MISL, AFL, AOL, FOX, UFC, NAAFS, Bellator, WEF, the Staples Center, the Orleans Arena, Oscar De La Hoya, Barbra Streisand, and top entertainment venues, acts and actors. His clients and companies have capitalized on Bell’s knowledge of the world of entertainment, live events, sports, digital television and digital online transaction and distribution systems.

B2Digital Inc. (BTDG), closed Wednesday's trading session at $0.0055, off by 25.6757%, on 1,482,400 volume with 7 trades. The average volume for the last 3 months is 168,953 and the stock's 52-week low/high is $0.0023/$0.039999999.

Recent News

chart

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

Xalles Holdings Inc. (OTC: XALL) has established its mission of supporting investment, financing and commerce systems in order to ensure that these financial transactions can take place unhindered by the multitude of challenges that the modern marketplace may pose – challenges that may include technological processing issues, language and cultural connections, security confidence or resource management efficiencies. Also today, CryptoCurrencyWire released a report on the company detailing how XALL leverages blockchain and other technologies for e-commerce, payments, financial-reconciliation, and payment-auditing solutions. To view the full article, visit http://ccw.fm/D9hXC.

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
All current subsidiaries are wholly owned

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Advancements in 2019

  • Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
  • Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
  • Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.

“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”

– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)

Xalles Holdings Inc. (OTC: XALL), closed Wednesday's trading session at $0.003, off by 14.2857%, on 4,000 volume with 1 trade. The average volume for the last 3 months is 2,960,337 and the stock's 52-week low/high is $0.0013/$0.021029999.

Recent News

chart

Neutra Corp. (OTCQB: NTRR)

The QualityStocks Daily Newsletter would like to spotlight Neutra Corp. (NTRR).

Neutra Corp. (OTCQB: NTRR) was featured today in a publication from CBDWire, examining how the popularity of CBD is growing constantly, with market forecasts indicating that the global CBD industry is likely to reach $22 billion by 2022 (http://cnw.fm/1nijW). One of the main reasons CBD’s popularity has exploded as of late is related to its multiple health benefits, according to clinical research. Various studies carried out over the years indicate that CBD has anti-inflammatory, anti-anxiety and cognitive-boosting qualities. Also today, the company was highlighted in a publication from HempWireNews, examining how, globally, industrial hemp is used in more than 250,000 products, and interest in this versatile plant doesn’t seem to have peaked just yet. For the first time, the World Ag Expo is going to feature a hemp pavilion where there will be space for exhibitors and a stage for seminars during the expo due to take place in February 2020.

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

  • Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
  • J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

  • Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
  • ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

Neutra Corp. (OTCQB: NTRR), closed Wednesday's trading session at $0.0008, off by 11.1111%, on 15,392,814 volume with 30 trades. The average volume for the last 3 months is 24,085,605 and the stock's 52-week low/high is $0.000799999/$0.094999998.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.